Navigating the realm of end-of-life care and access to medications like this drug in New South Wales, the state, requires a careful understanding of the complex legal structure. Currently, Nembutal does not have a approved place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not commonly prescribed by clinical professionals. It